Literature DB >> 22563170

siRNA targeting of Cdx2 inhibits growth of human gastric cancer MGC-803 cells.

Xiao-Tong Wang1, Yu-Bo Xie, Qiang Xiao.   

Abstract

AIM: To investigate the effects of small interference RNA (siRNA) targeting of Cdx2 on human gastric cancer MGC-803 cells in vitro and in vivo.
METHODS: The recombinant pSilencer 4.1-Cdx2 siRNA plasmids were constructed and transfected into gastric cancer MGC-803 cells in vitro. The stable transfectants were selected. The effects of Cdx2 siRNA on growth, proliferation, cell cycle, apoptosis, migration and invasiveness of human gastric cancer MGC-803 cells were evaluated and the expression of phosphatase and tensin homolog (PTEN), caspase-9 and caspase-3 was observed in vitro by reverse transcription polymerase chain reaction (RT-PCR) and Western blotting analysis. We also investigated the effect of Cdx2 siRNA on growth of MGC-803 cells in nude mice in vivo.
RESULTS: Cdx2 siRNA led to inhibition of endogenous Cdx2 mRNA and protein expression as determined by RT-PCR and Western blotting analysis. Cdx2 siRNA significantly inhibited cell growth and proliferation, blocked entry into the S-phase of the cell cycle, induced cell apoptosis, and reduced the motility and invasion of MGC-803 cells. Cdx2 siRNA also increased PTEN expression, and activated caspase-9 and caspase-3 in MGC-803 cells in vitro . In addition, siRNA targeting of Cdx2 inhibited the growth of MGC-803 cells and promoted tumor cell apoptosis in vivo in nude mice tumor models.
CONCLUSION: Cdx2 was involved in regulating pro-gression of human gastric cancer cells MGC-803. Manipulation of Cdx2 expression may be a potential therapeutic strategy for gastric cancer.

Entities:  

Keywords:  Cdx2; Gastric cancer; Growth; Small interference RNA

Mesh:

Substances:

Year:  2012        PMID: 22563170      PMCID: PMC3337565          DOI: 10.3748/wjg.v18.i16.1903

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  30 in total

1.  Down-regulation of the homeodomain factor Cdx2 in colorectal cancer by collagen type I: an active role for the tumor environment in malignant tumor progression.

Authors:  Thomas Brabletz; Simone Spaderna; Jochen Kolb; Falk Hlubek; Gerhard Faller; Christiane J Bruns; Andreas Jung; Jens Nentwich; Isabelle Duluc; Claire Domon-Dell; Thomas Kirchner; Jean-Noel Freund
Journal:  Cancer Res       Date:  2004-10-01       Impact factor: 12.701

2.  ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of gastric cancer.

Authors:  D Cunningham; L M Jost; G Purkalne; J Oliveira
Journal:  Ann Oncol       Date:  2005       Impact factor: 32.976

3.  Expression of intestine-specific transcription factors, CDX1 and CDX2, in intestinal metaplasia and gastric carcinomas.

Authors:  Raquel Almeida; Elisabete Silva; Filipe Santos-Silva; Debra G Silberg; Jiangfu Wang; Carmen De Bolós; Leonor David
Journal:  J Pathol       Date:  2003-01       Impact factor: 7.996

4.  Ectopic expression of homeodomain protein CDX2 in intestinal metaplasia and carcinomas of the stomach.

Authors:  Yun-Qing Bai; Hiroshi Yamamoto; Yoshimitsu Akiyama; Hiroyuki Tanaka; Touichirou Takizawa; Morio Koike; Osmar Kenji Yagi; Kiyoshi Saitoh; Kimiya Takeshita; Takehisa Iwai; Yasuhito Yuasa
Journal:  Cancer Lett       Date:  2002-02-08       Impact factor: 8.679

5.  Development of gastric carcinoma from intestinal metaplasia in Cdx2-transgenic mice.

Authors:  Hiroyuki Mutoh; Shinji Sakurai; Kiichi Satoh; Kiichi Tamada; Hiroto Kita; Hiroyuki Osawa; Takeshi Tomiyama; Yukihiro Sato; Hironori Yamamoto; Norio Isoda; Toru Yoshida; Kenichi Ido; Kentaro Sugano
Journal:  Cancer Res       Date:  2004-11-01       Impact factor: 12.701

6.  The Cdx2 homeobox gene has a tumour suppressor function in the distal colon in addition to a homeotic role during gut development.

Authors:  C Bonhomme; I Duluc; E Martin; K Chawengsaksophak; M-P Chenard; M Kedinger; F Beck; J-N Freund; C Domon-Dell
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

Review 7.  The role of Cdx proteins in intestinal development and cancer.

Authors:  Rong-Jun Guo; Eun Ran Suh; John P Lynch
Journal:  Cancer Biol Ther       Date:  2004-07-09       Impact factor: 4.742

8.  The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas.

Authors:  Vassil Kaimaktchiev; Luigi Terracciano; Luigi Tornillo; Hanspeter Spichtin; Dimitra Stoios; Marcel Bundi; Veselina Korcheva; Martina Mirlacher; Massimo Loda; Guido Sauter; Christopher L Corless
Journal:  Mod Pathol       Date:  2004-11       Impact factor: 7.842

9.  Colonic polyposis caused by mTOR-mediated chromosomal instability in Apc+/Delta716 Cdx2+/- compound mutant mice.

Authors:  Koji Aoki; Yoshitaka Tamai; Shigeo Horiike; Masanobu Oshima; Makoto M Taketo
Journal:  Nat Genet       Date:  2003-11-16       Impact factor: 38.330

Review 10.  Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health.

Authors:  William H Chappell; Linda S Steelman; Jacquelyn M Long; Ruth C Kempf; Stephen L Abrams; Richard A Franklin; Jörg Bäsecke; Franca Stivala; Marco Donia; Paolo Fagone; Graziella Malaponte; Maria C Mazzarino; Ferdinando Nicoletti; Massimo Libra; Danijela Maksimovic-Ivanic; Sanja Mijatovic; Giuseppe Montalto; Melchiorre Cervello; Piotr Laidler; Michele Milella; Agostino Tafuri; Antonio Bonati; Camilla Evangelisti; Lucio Cocco; Alberto M Martelli; James A McCubrey
Journal:  Oncotarget       Date:  2011-03
View more
  8 in total

1.  Reversal of multidrug resistance in gastric cancer cells by CDX2 downregulation.

Authors:  Lin-Hai Yan; Xiao-Tong Wang; Jie Yang; Chao Lian; Fan-Biao Kong; Wei-Yuan Wei; Wen Luo; Qiang Xiao; Yu-Bo Xie
Journal:  World J Gastroenterol       Date:  2013-07-14       Impact factor: 5.742

2.  E2F-1 overexpression inhibits human gastric cancer MGC-803 cell growth in vivo.

Authors:  Wei-Yuan Wei; Lin-Hai Yan; Xiao-Tong Wang; Lei Li; Wen-Long Cao; Xiao-Shi Zhang; Ze-Xu Zhan; Han Yu; Yu-Bo Xie; Qiang Xiao
Journal:  World J Gastroenterol       Date:  2015-01-14       Impact factor: 5.742

3.  Tumor-derived exosomes orchestrate the microRNA-128-3p/ELF4/CDX2 axis to facilitate the growth and metastasis of gastric cancer via delivery of LINC01091.

Authors:  Qiang Wang; Chunmei Zhang; Shengya Cao; Hongying Zhao; Rongke Jiang; Yanfang Li
Journal:  Cell Biol Toxicol       Date:  2022-06-08       Impact factor: 6.691

4.  Prognostic significance of Cdx2 immunohistochemical expression in gastric cancer: a meta-analysis of published literatures.

Authors:  Xiao-Tong Wang; Wei-Yuan Wei; Fan-Biao Kong; Chao Lian; Wen Luo; Qiang Xiao; Yu-Bo Xie
Journal:  J Exp Clin Cancer Res       Date:  2012-11-26

5.  Methylation of promoter region of CDX2 gene in colorectal cancer.

Authors:  Yunshuai Wang; Zhaohui Li; Wenxian Li; Shuaifeng Liu; Baowei Han
Journal:  Oncol Lett       Date:  2016-09-09       Impact factor: 2.967

6.  CDX2 and Reg IV expression and correlation in gastric cancer.

Authors:  Dandan Chai; Huifen Du; Kesheng Li; Xueliang Zhang; Xiaoqin Li; Xiaoning Zhao; Xiaowen Lian; Yang Xu
Journal:  BMC Gastroenterol       Date:  2021-02-27       Impact factor: 3.067

7.  microRNA-9 suppresses the proliferation, invasion and metastasis of gastric cancer cells through targeting cyclin D1 and Ets1.

Authors:  Liduan Zheng; Teng Qi; Dehua Yang; Meng Qi; Dan Li; Xuan Xiang; Kai Huang; Qiangsong Tong
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

8.  Downregulation of cellular prion protein inhibited the proliferation and invasion and induced apoptosis of Marek's disease virus-transformed avian T cells.

Authors:  Xuerui Wan; Runxia Yang; Guilin Liu; Manling Zhu; Tianliang Zhang; Lei Liu; Run Wu
Journal:  J Vet Sci       Date:  2016-06-30       Impact factor: 1.672

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.